Guo Fei, Wu Yizhan, Wang Guangjun, Liu Jiangwei
Department of Emergency Trauma Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Graduate School of Xinjiang Medical University, Urumqi, China.
J Nanobiotechnology. 2024 Dec 27;22(1):800. doi: 10.1186/s12951-024-02889-4.
This study aims to elucidate the mechanisms by which nanovesicles (NVs) transport curcumin(CUR) across the blood-brain barrier to treat hypothalamic neural damage induced by heat stroke by regulating the expression of poly(c)-binding protein 2 (PCBP2).
Initially, NVs were prepared from macrophages using a continuous extrusion method. Subsequently, CUR was loaded into NVs using sonication, yielding engineered cell membrane Nanovesicles loaded with curcumin (NVs-CUR), which were characterized and subjected to in vitro and in vivo tracking analysis. Evaluations included assessing the toxicity of NVs-CUR using the MTT assay, evaluating neuroprotection of NVs-CUR against HO-induced oxidative stress damage in PC12 cells, examining effects on cell morphology and quantity, and detecting ferroptosis-related markers through Western blot and transmission electron microscopy (TEM). Proteomic analysis was conducted on PC12 cells treated with NVs (n = 3) and NVs-CUR (n = 3) to identify downstream key factors. Subsequently, the expression of key factors was modulated, and rescue experiments were performed to validate the impact of NVs-CUR through the regulation of key factor expression. Furthermore, a mouse model of hypothalamic neural damage induced by heat stroke was established, where CUR, NVs-CUR, and ferroptosis inducer Erastin were administered to observe mouse survival rates, conduct nerve function deficit scoring, perform histological staining, and measure levels of inflammation and oxidative stress factors in hypothalamic tissue.
NVs-CUR was successfully prepared with excellent stability, serving as an advantageous drug delivery system that effectively targets brain injury sites or neurons both in vitro and in vivo. Subsequent in vitro cell experiments demonstrated the biocompatibility of NVs-CUR, showing superior protective effects against HO-induced PC12 cell damage and reduced ferroptosis compared to CUR. Moreover, in the mouse model of hypothalamic neural damage induced by heat stroke, NVs-CUR exhibited enhanced therapeutic effects. Proteomic analysis revealed that NVs-CUR exerted its effects through the regulation of key protein PCBP2; silencing PCBP2 reversed the protective effect of NVs-CUR on neural damage and its inhibition of ferroptosis. Additionally, NVs-CUR regulated solute carrier family 7 member 11 (SLC7A11) expression by PCBP2; overexpression of SLC7A11 reversed the promotion of neural damage and ferroptosis by silencing PCBP2. Animal experiments indicated that ferroptosis inducers reversed the improved survival and nerve function observed with NVs-CUR, silencing PCBP2 reversed the ameliorative effects of NVs-CUR on hypothalamic neural injury induced by heat stroke, and overexpression of SLC7A11 further reversed the adverse effects of silencing PCBP2 on hypothalamic neural injury induced by heat stroke. This suggests that NVs-CUR alleviates hypothalamic neural damage induced by heat stroke by targeting the PCBP2/SLC7A11 axis to reduce neuronal ferroptosis.
This study successfully developed engineered cell membrane NVs-CUR with neuron-targeting properties. NVs-CUR increased the expression of PCBP2, maintained the stability of SLC7A11 mRNA, reduced ferroptosis, and ultimately alleviated hypothalamic neuroinflammation induced by heatstroke.
本研究旨在阐明纳米囊泡(NVs)通过调节多聚(c)结合蛋白2(PCBP2)的表达将姜黄素(CUR)转运穿过血脑屏障以治疗中暑诱导的下丘脑神经损伤的机制。
首先,采用连续挤压法从巨噬细胞制备NVs。随后,通过超声处理将CUR负载到NVs中,得到负载姜黄素的工程化细胞膜纳米囊泡(NVs-CUR),对其进行表征并进行体外和体内追踪分析。评估包括使用MTT法评估NVs-CUR的毒性,评估NVs-CUR对HO诱导的PC12细胞氧化应激损伤的神经保护作用,检查对细胞形态和数量的影响,以及通过蛋白质印迹和透射电子显微镜(TEM)检测铁死亡相关标志物。对用NVs(n = 3)和NVs-CUR(n = 3)处理的PC12细胞进行蛋白质组学分析以鉴定下游关键因子。随后,调节关键因子的表达,并进行拯救实验以验证NVs-CUR通过调节关键因子表达的影响。此外,建立中暑诱导的下丘脑神经损伤小鼠模型,给予CUR、NVs-CUR和铁死亡诱导剂Erastin,观察小鼠存活率,进行神经功能缺损评分,进行组织学染色,并测量下丘脑组织中炎症和氧化应激因子水平。
成功制备了具有优异稳定性的NVs-CUR,其作为一种有利的药物递送系统,在体外和体内均能有效靶向脑损伤部位或神经元。随后的体外细胞实验证明了NVs-CUR的生物相容性,与CUR相比,其对HO诱导的PC12细胞损伤具有优异的保护作用,并减少了铁死亡。此外,在中暑诱导的下丘脑神经损伤小鼠模型中,NVs-CUR表现出增强的治疗效果。蛋白质组学分析表明,NVs-CUR通过调节关键蛋白PCBP2发挥作用;沉默PCBP2可逆转NVs-CUR对神经损伤的保护作用及其对铁死亡的抑制作用。此外,NVs-CUR通过PCBP2调节溶质载体家族7成员11(SLC7A11)的表达;SLC7A11的过表达可逆转沉默PCBP2对神经损伤和铁死亡的促进作用。动物实验表明,铁死亡诱导剂可逆转NVs-CUR观察到的存活率提高和神经功能改善,沉默PCBP2可逆转NVs-CUR对中暑诱导的下丘脑神经损伤的改善作用,SLC7A11的过表达进一步逆转了沉默PCBP2对中暑诱导的下丘脑神经损伤的不利影响。这表明NVs-CUR通过靶向PCBP2/SLC7A11轴减轻中暑诱导的下丘脑神经损伤,以减少神经元铁死亡。
本研究成功开发了具有神经元靶向特性的工程化细胞膜NVs-CUR。NVs-CUR增加了PCBP2的表达,维持了SLC7A11 mRNA的稳定性,减少了铁死亡,并最终减轻了中暑诱导的下丘脑神经炎症。